NEUROBIOLOGICAL FACTORS INVOLVED IN MIGRAINE GENESIS

Authors

DOI:

https://doi.org/10.47820/recima21.v4i12.4089

Keywords:

Genetic factors; Neurotransmitters; Brain plasticity.

Abstract

Introduction: Migraine, one of the most prevalent and debilitating neurological conditions worldwide, has been the subject of intensive investigations aimed at understanding the complex neurobiological factors that contribute to its genesis. Objective: To investigate the neurobiological mechanisms of migraine and possible therapeutic approaches. Methodology: We performed a search in renowned scientific databases, including PubMed, Scopus and Web of Science, selecting studies published between 2013 and 2023 that addressed the neurobiological factors of migraine. Results and Discussion: We identified genetic influence, with variants such as MTHFR increasing the risk of migraine. Glutamatergic neurotransmission and central sensitization play crucial roles in generating pain. Activation of the trigemino-vascular system and neurogenic inflammation are implicated in seizures. Emerging therapeutic targets, such as CGRP receptor antagonists, show efficacy in prevention. Conclusion: This review covers a comprehensive overview of neurobiological factors in migraine, highlighting the importance of understanding these mechanisms for more targeted therapies. This knowledge offers new perspectives for the effective management of this debilitating condition, improving patients' quality of life.

Downloads

Download data is not yet available.

Author Biographies

  • Ana Maria Santos Cardoso

    Instituto de Educação Superior do Vale do Parnaíba-IESVAP.

     

  • Vitória Miranda Eustáquio

    Instituto de Educação Superior do Vale do Parnaíba-IESVAP.

  • Waleska Vitória de Oliveira Tostes Peixoto

    Instituto de Educação Superior do Vale do Parnaíba-IESVAP.

  • Suzana Gabriela Ferreira Santos

    Estácio - IDOMED.

  • João Sérgio de Sousa Moura

    Instituto de Educação Superior do Vale do Parnaíba-IESVAP.

  • Antônio Valdir Soares de Sousa Júnior

    Uninovafapi.

  • Larissa Nunes Castro

    Uninovafapi.

  • Diego di Laurentis dos Santos Souza

    Instituto de Educação Superior do Vale do Parnaíba-IESVAP.

  • Gabriel Medeiros Oliveira Pires

    Instituto de Educação Superior do Vale do Parnaíba-IESVAP.

  • Amannda Maria Neiva dos Santos

    Instituto de Educação Superior do Vale do Parnaíba-IESVAP.

References

ANTTILA, V.; WINSVOLD, B. S.; GORMLEY, P.; KURTH, T.; BETTELLA, F.; MCMAHON, G.; PALTA, P. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nature Genetics, v. 45, n. 8, p. 912-917, 2017.

ASHINA, M.; GOADSBY, P. J.; REUTER, U. et al. Targeting the trigeminovascular pathway in migraine. Cephalalgia, v. 40, n. 12, p. 1485-1493, 2020.

CHARLES, A. Migraine: a brain state. Current Opinion in Neurology, v. 26, n. 3, p. 235-239, 2013.

CHONG, C. D.; SCHWEDT, T. J.; DODICK, D. W. Migraine: what imaging reveals. Neuroimaging Clinics of North America, v. 29, n. 4, p. 445-460, 2019.

COPPOLA, G.; DI RENZO, A.; TINELLI, E.; DI LORENZO, C.; SCAPECCIA, M.; PARISI, V.; PASCUAL, J. The CNS–peripheral nervous system relationship to the NMDA receptor in migraine: A review. The Journal of Headache and Pain, v. 16, n. 1, p. 1-9, 2015.

EDVINSSON, L.; WARFVINGE, K. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment. Cephalalgia, v. 39, n. 3, p. 366-373, 2019.

GORMLEY, P.; ANTTILA, V.; WINSVOLD, B. S.; PALTA, P.; ESKO, T.; PERS, T. H.; TZOURIO, C. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nature Genetics, v. 48, n. 8, p. 856-866, 2016.

LEVY, D.; BURSTEIN, R.; KAINZ, V.; JAKUBOWSKI, M.; STRASSMAN, A. M. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain, v. 159, n. 3, p. 193-208, 2018.

LIPTON, R. B.; DODICK, D. W.; SILBERSTEIN, S. D. et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia, v. 36, n. 10, p. 957-970, 2015.

LIPTON, R. B.; SILBERSTEIN, S. D. Episodic and chronic migraine headache: Breaking down barriers to optimal treatment and prevention. Headache: The Journal of Head and Face Pain, v. 55, n. S2, p. 103-122, 2015.

NOSEDA, R.; BURSTEIN, R. Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain, v. 154, n. Suppl 1, p. S44-S53, 2013.

NOSEDA, R.; SCHAIN, A. J.; MELO-CARRILLO, A. et al. Neural mechanism of migraine. Neuron, v. 109, n. 3, p. 406-420, 2021.

PEROUTKA, S. J. What turns on a migraine? A systematic review of migraine precipitating factors. Current Pain and Headache Reports, v. 18, n. 10, p. 454, 2014.

PIETROBON, D.; MOSKOWITZ, M. A. Pathophysiology of migraine. Annual Review of Physiology, v. 75, p. 365-391, 2013.

RUSSO, A. F.; KUNKEL, R. Calcitonin gene-related peptide (CGRP) and migraine. Handbook of Experimental Pharmacology, v. 255, p. 121-130, 2019.

RUSSO, A. F.; KUNKEL, R. Revisiting the Neurogenic Inflammation in Migraine. Neurotherapeutics, v. 16, n. 1, p. 15-24, 2019.

Published

13/12/2023

How to Cite

NEUROBIOLOGICAL FACTORS INVOLVED IN MIGRAINE GENESIS. (2023). RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 4(12), e4124089. https://doi.org/10.47820/recima21.v4i12.4089